Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-28

Clinical Trial Update: Hypofractionated vs Conventional Fractionated RT in Soft Tissue Sarcomas [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial compares hypofractionated versus conventional fractionated radiotherapy in soft tissue sarcoma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Soft Tissue Sarcoma | Phase 2 | Status: RECRUITING